glp-1-based treatments approved for weight loss 2025 The FDA has the first GLP-1 pill loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular Myths & Facts: GLP-1 Drugs

Yes, GLP-1based medications are considered safe when administered under the supervision of a qualified healthcare provider

SGLT-2 inhibitors: the gap seems to be leveling off

Most patients reach Wegovy HD around 45 months after starting treatment

The FDA label includes a boxed warning regarding thyroid C-cell tumors observed in rodent studies, with contraindications for patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

What to do: Focus on balanced, nutrient-dense meals Prioritise protein, vegetables, and healthy fats in each serving Plan ahead to make every bite count Nausea and Diarrhoea Are Common Side Effects Over 1 in 10 people experience nausea or diarrhoea while taking GLP-1 medications